3750 fundamentals
Key facts
Cytori Cell Research Institute, Inc. operates as a holding company, which provides financial and marketing-related services. The firm operates in the Medical Business and Real Asset Business segments. The Medical Business segment involves in the provision of cell therapy services and consists of subsidiaries that sell Cellution Centrifuge and patented technology that uses the same system to extract adipose tissue-derived regenerative cells and adipose derived regenerative cells. The Real Asset Business segment deals with hotel operations and real estate division businesses. The company was founded on October 1, 2004 and is headquartered in Tokyo, Japan.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
Financial health
Financial position and solvency of the company